The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: So just drill down into Larry's questions a little further. Just in the peripheral market. Is there anything specific or any area that -- you
mentioned DVT, but DVT versus PE versus other areas that you're seeing the bulk of the growth come from?
And then also piggyback on the international question. In the opening remarks, you discussed some changes to that international
structure of really splitting the sales forces. Is that something that could be accomplished rather quickly, where it's in place by
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
OCTOBER 28, 2020 / 8:30PM, PEN.N - Q3 2020 Penumbra Inc Earnings Call
year-end this year and then you're kind of '21 hit the ground running? Or is this kind of a rolling adjustment we'll see over time to
that channel?
Question: William John Plovanic - Canaccord Genuity Corp., Research Division - Analyst
: Okay. And if I could ask a follow-up. It's just on the $20.7 million in onetime charges with Lightning, can you give a little granularity
on what specifically that would be for?
Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
: Congrats on a nice quarter. Adam, I know you don't get asked a lot on REAL VR, but there have been reimbursement changes, and
you highlighted it in the script. I was wondering how people should think about that over, let's say, the next 2 to 4 years here. Is this
something that can start to contribute to revenue at the closer end of that time range? Or is this really still some opportunity that's
exciting or -- and -- but further out?
Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
: Great. And maybe a quick follow-up. Your competitor in peripheral aspiration has a higher price point than you based on, I believe,
your comments and some of the checks we've done. How should we think about the third quarter U.S. peripheral performance in
terms of price versus volume? If you don't want to tell us exactly, any qualitative measures would be really helpful, getting us in the
right direction.
|
